$100.97
+3.09
(+3.16%)
As of Oct 22, 2026, 9:34 PM EDT · cached
Price history
Healthequity Inc (HQY) is trading up at $100.97 (+3.16%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Healthequity Inc revenue & net income history (FY2017–FY2026)
RevenueNet incomeNet margin (right axis, %)
| FY2017Jan 2017 | FY2018Jan 2018 | FY2019Jan 2019 | FY2020Jan 2020 | FY2021Jan 2021 | FY2022Jan 2022 | FY2023Jan 2023 | FY2024Jan 2024 | FY2025Jan 2025 | FY2026Jan 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $178.4M | $229.5M | $287.2M | $532.0M | $733.6M | $756.6M | $861.7M | $999.6M | $1.20B | $1.31B |
| Growth (year over year) | +40.7% | +28.7% | +25.1% | +85.2% | +37.9% | +3.1% | +13.9% | +16.0% | +20.0% | +9.5% |
| Gross profit | $106.4M | $134.9M | $181.2M | $325.9M | $415.3M | $424.8M | $491.9M | $622.6M | $777.3M | $913.1M |
| Gross margin | 59.6% | 58.8% | 63.1% | 61.3% | 56.6% | 56.1% | 57.1% | 62.3% | 64.8% | 69.5% |
| Operating income | $41.2M | $54.4M | $77.7M | $77.0M | $34.0M | −$24.2M | $9.06M | $117.7M | $162.3M | $322.5M |
| Operating margin | 23.1% | 23.7% | 27.0% | 14.5% | 4.6% | −3.2% | 1.1% | 11.8% | 13.5% | 24.6% |
| Net income | $26.4M | $47.4M | $73.9M | $39.7M | $8.83M | −$44.3M | −$26.1M | $55.7M | $96.7M | $215.2M |
| Net margin | 14.8% | 20.6% | 25.7% | 7.5% | 1.2% | −5.9% | −3.0% | 5.6% | 8.1% | 16.4% |
| EPS (diluted) | $0.44 | $0.77 | $1.17 | $0.58 | $0.12 | −$0.53 | −$0.31 | $0.64 | $1.09 | $2.46 |
| Balance sheet | ||||||||||
| Cash and equivalents | $140.0M | $199.5M | $361.5M | $191.7M | $328.8M | $225.4M | $254.3M | $404.0M | $295.9M | $318.9M |
| Total assets | $279.1M | $369.2M | $510.0M | $2.56B | $2.71B | $3.11B | $3.09B | $3.16B | $3.45B | $3.38B |
| Total liabilities | $17.2M | $22.9M | $32.9M | $1.53B | $1.33B | $1.25B | $1.19B | $1.13B | $1.33B | $1.27B |
| Long-term debt | — | — | $0 | $1.18B | $924.2M | $922.1M | $907.8M | $875.0M | $1.06B | $957.4M |
| Shareholders' equity | $261.9M | $346.3M | $477.1M | $1.03B | $1.38B | $1.85B | $1.90B | $2.04B | $2.11B | $2.11B |
| Cash flow | ||||||||||
| Operating cash flow | $45.6M | $81.7M | $113.4M | $105.0M | $181.6M | $141.0M | $150.7M | $242.8M | $339.9M | $457.1M |
| Capital expenditure | $3.65M | $5.46M | $3.87M | $7.29M | $13.1M | $8.91M | $3.37M | $1.69M | $2.08M | $1.97M |
| Free cash flow | $41.9M | $76.2M | $109.6M | $97.7M | $168.5M | $132.1M | $147.3M | $241.1M | $337.8M | $455.1M |
| Dividends paid | $0 | — | — | — | — | — | — | — | — | — |
| Share buybacks | — | — | — | — | — | — | $0 | $0 | $121.5M | $299.3M |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY25Oct 2024 | Q4 FY25†Jan 2025 | Q1 FY26Apr 2025 | Q2 FY26Jul 2025 | Q3 FY26Oct 2025 | Q4 FY26†Jan 2026 | Q1 FY27Apr 2026 | Q2 FY27Jul 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $300.4M | $311.8M | $330.8M | $325.8M | $322.2M | $334.6M | $354.6M | $350.7M |
| Growth (year over year) | +20.5% | +18.8% | +15.0% | +8.6% | +7.2% | +7.3% | +7.2% | +7.6% |
| Gross profit | $197.0M | $189.0M | $224.3M | $232.6M | $228.1M | $228.1M | $256.3M | $258.0M |
| Gross margin | 65.6% | 60.6% | 67.8% | 71.4% | 70.8% | 68.2% | 72.3% | 73.5% |
| Operating income | $19.6M | $42.1M | $83.1M | $89.6M | $78.7M | $71.1M | $103.0M | $98.7M |
| Operating margin | 6.5% | 13.5% | 25.1% | 27.5% | 24.4% | 21.2% | 29.0% | 28.1% |
| Net income | $5.70M | $26.4M | $53.9M | $59.9M | $51.7M | $49.7M | $69.4M | $65.6M |
| Net margin | 1.9% | 8.5% | 16.3% | 18.4% | 16.0% | 14.9% | 19.6% | 18.7% |
| EPS (diluted) | $0.06 | $0.30 | $0.61 | $0.68 | $0.59 | $0.58 | $0.82 | $0.78 |
| Balance sheet | ||||||||
| Cash and equivalents | $322.2M | $295.9M | $287.9M | $304.5M | $309.3M | $318.9M | $265.4M | $256.0M |
| Total assets | $3.49B | $3.45B | $3.42B | $3.42B | $3.40B | $3.38B | $3.31B | $3.27B |
| Total liabilities | $1.36B | $1.33B | $1.29B | $1.27B | $1.26B | $1.27B | $1.26B | $1.28B |
| Long-term debt | $1.08B | $1.06B | $1.06B | $1.01B | $982.1M | $957.4M | $942.7M | $931.1M |
| Shareholders' equity | $2.12B | $2.11B | $2.12B | $2.15B | $2.13B | $2.11B | $2.05B | $1.99B |
| Cash flow | ||||||||
| Operating cash flow | $90.5M | $75.7M | $64.7M | $135.9M | $138.6M | $117.9M | $97.5M | $136.2M |
| Capital expenditure | $294.0K | $328.0K | $86.0K | $773.0K | $784.0K | $326.0K | $362.0K | $978.0K |
| Free cash flow | $90.3M | $75.4M | $64.7M | $135.1M | $137.8M | $117.6M | $97.2M | $135.2M |
| Share buybacks | $58.5M | $63.0M | $59.1M | $66.7M | $92.4M | $81.0M | $123.3M | $107.7M |
From Healthequity Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in January. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Healthequity Inc
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with.
Source: Wikipedia — HealthEquity
- Headquarters
- Draper, Utah From SEC filings, Oct 2026
Recent News (5)
-
HealthEquity EVP Sunil Rajasekar sells $13,309 in stock
HealthEquity EVP Sunil Rajasekar sells $13,309 in stock
-
Jefferies examines HealthEquity stock short interest rise
Jefferies examines HealthEquity stock short interest rise
-
Parloa to Unveil What's Next in Agentic Customer Experience at WAVE 2026 Berlin New product innovations, live demos and insights from leaders at OpenAI, Microsoft, SAP, IKEA, HealthEquity and more will take center stage at Parloa's flagship AI + CX event NEW YORK and BERLIN, Sept…
-
S&P Global upgrades HealthEquity rating on strong performance
S&P Global upgrades HealthEquity rating on strong performance
-
Market Movers | Winners: OKTA, CRM, CRWD | Losers: BBW, WEN, HQY Market Movers | Winners: OKTA, CRM, CRWD | Losers: BBW, WEN, HQY Trefis
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International